We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

New York Cannabis Regulator Removes Yeast and Mold Testing Requirement

The state’s Office of Cannabis Management has removed the pass/fail limits associated with the total yeast and mold counts for cannabis flower and pre-rolls.

Read More

New York Regulator Issues Guidance For Cannabis Retailers

Recreational cannabis retailers in New York will have to be separated from the plant’s production under new guidance issued by state regulators.

Read More

Colorado’s Cannabis Regulator Issues Warning About Moldy Cannabis Flower

Regulators in Colorado have found “potentially unsafe” levels of Aspergillus mold on batches of medical cannabis flower.

Read More

Don't Deny Cannabis Consumers Heart Transplants, Say Cardiologists

The researchers argue that the medical establishment should find a new approach to determining transplant candidacy for cannabis users.

Read More

Germany Formally Announces its Cannabis Legalization Plan

Germany’s full legalization plan has been revealed by the country’s health minister.

Read More

Pennsylvania Regulator Adds ‘Two-Lab’ Rule For Cannabis Testing

Pennsylvania’s cannabis regulator recently approved the “final regulations” for the state’s medical cannabis program – and the new rules include one controversial requirement.

Read More

California Lawsuit Alleges Cannabis Company Exaggerated THC Levels of Products

A California-based cannabis company has been accused of inflating the THC levels of its products.

Read More

Cannabis Dependence Linked to Post-Surgery Complications, Study Finds

People who are dependent on cannabis tend to have higher rates of infection following knee and shoulder keyhole surgeries, a new study has found.

Read More

Hong Kong to Ban CBD

The Hong Kong government will reportedly outlaw the cannabis compound by February 1, 2023, and place “it in the same category as heroin, cocaine and methamphetamine”.

Read More

 
Advertisement